| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/17/2004 | EP1397147A1 Use of adenosine a1 agonists in the treatment of emesis |
| 03/17/2004 | EP1397146A2 Compositions and methods for inhibiting bone resorption |
| 03/17/2004 | EP1397145A2 Use of cox-2 inhibitors for the treatment of schizophrenia, delusional disorders, affective disorders, autism or tic disorders |
| 03/17/2004 | EP1397143A1 Estriol therapy for multiple sclerosis and other autoimmune diseases |
| 03/17/2004 | EP1397142A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 03/17/2004 | EP1397141A2 Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments |
| 03/17/2004 | EP1397140A2 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways |
| 03/17/2004 | EP1397139A1 Pharmaceutical combinations |
| 03/17/2004 | EP1397138A2 Active ingredient combination for treating a dependence on addictive substances or narcotics using medicaments |
| 03/17/2004 | EP1397137A1 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP1397136A1 Heterocyclic beta-aminoacids and their use as anti-epileptogenic agents |
| 03/17/2004 | EP1397135A2 Combination of a pde4 inhibitor and tiotropium or derivative thereof for treating obstructive airways |
| 03/17/2004 | EP1397134A2 Combination of a dopamine d2-receptor agonist and tiotropium or a derivative therof for treating obstructive airways |
| 03/17/2004 | EP1397133A1 Rapid onset formulation |
| 03/17/2004 | EP1397132A1 Pirenzepine ophthalmic gel |
| 03/17/2004 | EP1397131A1 Compositions comprising nitrofurantoin and uva ursi |
| 03/17/2004 | EP1397130A1 Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 03/17/2004 | EP1397129A1 Heteroaryloxy 3-substituted propanamines s serotonin and norepinephrine reuptake inhibitors |
| 03/17/2004 | EP1397128A1 Kappa opiate agonists for the treatment of bladder diseases |
| 03/17/2004 | EP1397127A1 Solid pharmaceutucal formulations comprising modafinil |
| 03/17/2004 | EP1397126A2 Method of delaying ejaculation |
| 03/17/2004 | EP1397125A2 Compressible guaifenesin compositions and method for producing them |
| 03/17/2004 | EP1397124A2 Use of antidiabetics for making a medicine with cicatrizing effect |
| 03/17/2004 | EP1397105A1 Methods for inhibiting angiogenesis |
| 03/17/2004 | EP1397053A1 Oral composition comprising an extract from the bark of albizzia myriophylla |
| 03/17/2004 | EP1397044A1 Prebiotic and probiotic compositions and methods for their use in gut-based therapies |
| 03/17/2004 | EP1397041A1 Conjugated nonadecadienoic acid compositions |
| 03/17/2004 | EP1307218A4 Obesity controlling method |
| 03/17/2004 | EP1305318B1 Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b] [1,3]benzothiazepines |
| 03/17/2004 | EP1292597B1 Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them |
| 03/17/2004 | EP1292316A4 Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use |
| 03/17/2004 | EP1259112A4 Nutritional intervention composition for enhancing and extending satiety |
| 03/17/2004 | EP1246816B1 Substituted phenyl-piperazine derivatives, their preparation and use |
| 03/17/2004 | EP1246815B1 Phenylpiperazinyl derivatives |
| 03/17/2004 | EP1244434B1 Use of chemotherapeutic agents |
| 03/17/2004 | EP1242406B1 Novel compounds |
| 03/17/2004 | EP1242364B1 Adamantane derivatives |
| 03/17/2004 | EP1242119B1 Combinations for the treatment of dna viral infections comprising a loop diuretic and a cardiac glycoside |
| 03/17/2004 | EP1242105B1 Combination of ginseng and ginkgo to improve cognitive skills |
| 03/17/2004 | EP1224175B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 03/17/2004 | EP1202719A4 Anesthetic composition for intravenous injection comprising propofol |
| 03/17/2004 | EP1192154B1 Bispidine compounds useful in the treatment of cardiac arrhythmias |
| 03/17/2004 | EP1147102B1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 03/17/2004 | EP1146865B9 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol |
| 03/17/2004 | EP1144413B1 2,5-diazabicyclo 2.2.1]heptane derivatives, their preparation and therapeutic uses |
| 03/17/2004 | EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion |
| 03/17/2004 | EP1143917B1 Anticonvulsant derivatives useful in treating post traumatic stress disorder |
| 03/17/2004 | EP1140936B1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/17/2004 | EP1140932B1 1,8-benzonaphthyridine derivatives |
| 03/17/2004 | EP1140839B1 Heterocyclic amides as inhibitors of factor xa |
| 03/17/2004 | EP1140820B1 New amidino derivatives and their use as thrombin inhibitors |
| 03/17/2004 | EP1140810B1 Benzenic sulphonamide derivatives and their uses |
| 03/17/2004 | EP1140802B1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
| 03/17/2004 | EP1137644B9 Benzofuran derivatives, their preparation and use |
| 03/17/2004 | EP1137497B1 Apparatus for separating particles of cohesive material according to size and process |
| 03/17/2004 | EP1135391B1 Novel triazolo(4,5-d)pyrimidine compounds |
| 03/17/2004 | EP1100792B1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP1097148B1 Polymorph of ritonavir |
| 03/17/2004 | EP1091946B1 New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use |
| 03/17/2004 | EP1079851A4 Use of anti-prolactin agents to treat proliferative conditions |
| 03/17/2004 | EP1071684B1 IMIDAZO 1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS |
| 03/17/2004 | EP1051181B1 Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof |
| 03/17/2004 | EP1047695B1 Novel bispidine antiarrhythmic compounds |
| 03/17/2004 | EP1039890B1 Novel salts of metformin and method |
| 03/17/2004 | EP1030686B1 Lyophilizate of lipid complex of water insoluble porphyrins |
| 03/17/2004 | EP1021183B1 A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST |
| 03/17/2004 | EP1019714A4 Diagnosis of williams syndrome and williams syndrome cognitive profile by analysis of the presence or absence of a lim-kinase gene |
| 03/17/2004 | EP1012154B1 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof |
| 03/17/2004 | EP1008594B1 Compounds derived from thophene and benzothiophene, and related utilisation and composition |
| 03/17/2004 | EP1003558B1 Lipid-polyamide conjugates and compositions for nucleic acid delivery |
| 03/17/2004 | EP0971588B1 Novel cannabinoid receptor modulators |
| 03/17/2004 | EP0948328B1 Compositions based on aminoacids |
| 03/17/2004 | EP0925301B1 Highly lipophilic camptothecin derivatives |
| 03/17/2004 | EP0891362B1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 03/17/2004 | EP0891332B1 6-phenylpyridyl-2-amine derivatives |
| 03/17/2004 | EP0866655B1 Murine model for human carcinoma |
| 03/17/2004 | EP0825885B1 Pulmonary delivery of aerosolized medicaments |
| 03/17/2004 | EP0806955B1 Enrofloxacine injection or infusion solutions |
| 03/17/2004 | EP0731807B1 N-2 substituted purines |
| 03/17/2004 | EP0655917B1 Crystalline amifostine compositions and methods for the preparation and use of same |
| 03/17/2004 | CN1483079A Immunoregulation polynucleotide and using method thereof |
| 03/17/2004 | CN1483043A Chitosan-containing multicomponent composition and process for preparing the same |
| 03/17/2004 | CN1483039A Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 03/17/2004 | CN1483035A Sulfamidothienopyrimidines |
| 03/17/2004 | CN1483034A Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 03/17/2004 | CN1483033A Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 03/17/2004 | CN1483032A Process for making substituted 8-arylquinolinium benzenesulfonate |
| 03/17/2004 | CN1483031A Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them |
| 03/17/2004 | CN1483030A Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for the treatment of nervous system disorders |
| 03/17/2004 | CN1483029A Sodium channel modulators derived from 2-piperidylimidazoles |
| 03/17/2004 | CN1483028A Quinolinone derivatives as tyrosine kinase inhibitors |
| 03/17/2004 | CN1483026A Benzoylpyridazine |
| 03/17/2004 | CN1483025A Chemical compounds |
| 03/17/2004 | CN1483023A 3-arylindole derivatives and their use as cb2 receptor agonists |
| 03/17/2004 | CN1483022A Crystalline forms of atorvastatin |
| 03/17/2004 | CN1483021A Novel 1, 2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| 03/17/2004 | CN1483019A Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 03/17/2004 | CN1482921A Compositions of estrogen-cyclodextrin complexes |
| 03/17/2004 | CN1482920A Compositions for the treatment of coccidiosis |
| 03/17/2004 | CN1482914A Remedies for hepatitis c |